The Secretary of Foreign Relations of Mexico, Marcelo Ebrard, presented on Tuesday the portfolio of options that Mexico has for access to a potential vaccine against covid-19.
The Mexican Foreign Minister reported that phase 3 clinical trials of the Chinese CanSino Biologics vaccine are being carried out in the country in the states of Oaxaca and Guerrero, and mentioned that there are also agreements with Pfizer, Moderna, Oxford, Novavax, and the Russian vaccine Sputnik V.